A super deal today
The two drug manufacturers stand behind some of the industry's most striking responses to the Covid-19 pandemic are considering the possibility of a future of cooperation as economies have just emerged from a blockade. AstraZeneca, co-developer of one of the fastest-growing experimental coronavirus vaccines, made a preliminary approach with Gilead Science, the manufacturer of remdesivir - the only available treatment was approved by United States . If they decide to pursue the merger, this will be the largest deal ever in this area, giving AstraZeneca a market capitalization of over $ 200 billion.
Good news for all traders!
Nguyen
暂无评论,立马抢沙发